<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Inverse correlations of <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> D (ApoD) expression with <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> have been shown, therefore proposing ApoD as a good prognostic marker for diverse <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types, including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Besides, ApoD expression is boosted upon <z:mp ids='MP_0003674'>oxidative stress</z:mp> (OS) in many pathological situations </plain></SENT>
<SENT sid="2" pm="."><plain>This study aims at understanding the role of ApoD in the progression of human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Samples of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and distant <z:mpath ids='MPATH_458'>normal</z:mpath> tissue (n = 51) were assayed for levels of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation, expression profile of OS-dependent genes, and protein expression </plain></SENT>
<SENT sid="4" pm="."><plain>Three single-nucleotide polymorphisms in the ApoD gene were analyzed (n = 139), with no significant associations found </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, we assayed the effect of ApoD in proliferation and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> HT-29 cell line </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, <z:chebi fb="23" ids="18059">lipid</z:chebi> <z:chebi fb="39" ids="44785">peroxides</z:chebi> increase while ApoD <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> and protein decrease through <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e>, with a prominent decrease in stage I </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa, ApoD protein is present in lamina propia and enteroendocrine cells </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, ApoD expression is <z:hpo ids='HP_0001425'>heterogeneous</z:hpo>, with low expression in stromal cells commonly associated with high expression in the dysplastic epithelium </plain></SENT>
<SENT sid="9" pm="."><plain>ApoD promoter is basally methylated in HT-29 cells but retains the ability to respond to OS </plain></SENT>
<SENT sid="10" pm="."><plain>Exogenous addition of ApoD to HT-29 cells does not modify proliferation or <z:mpath ids='MPATH_3'>apoptosis</z:mpath> levels in control conditions, but it promotes <z:mpath ids='MPATH_3'>apoptosis</z:mpath> upon <z:chebi fb="11" ids="34905">paraquat</z:chebi>-induced OS </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Our results show ApoD as a gene responding to OS in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment </plain></SENT>
<SENT sid="12" pm="."><plain>Besides using ApoD as marker of initial stages of <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e>, it can become a therapeutic tool promoting <z:hpo ids='HP_0011420'>death</z:hpo> of proliferating <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells suffering OS </plain></SENT>
</text></document>